Purpose: To determine whether hypoxia preconditioning can protect corneal endothelial cells from mechanical stress and perioperative procedures mimicking Descemet stripping automated endothelial keratoplasty (DSAEK).
ndothelial keratoplasty (EK) is a surgical technique in which the damaged and depleted endothelial cells of the host cornea are selectively replaced with healthy donor endothelial cells. 1 EK is the preferred surgical procedure for diseases that specifically affect the corneal endothelium, such as Fuchs endothelial corneal dystrophy and pseudophakic bullous keratopathy. 2 The advantages of EK over penetrating keratoplasty include rapid visual recovery, faster wound healing, reduced graft rejection, and preservation of globe integrity and strength. 2 Although EK has revolutionized keratoplasty techniques, it is not without its own set of difficulties and challenges. 2 The surgical procedure of EK exerts a significant amount of stress on the donor endothelium, leading to perioperative cell loss, which can be as high as 40% of the total endothelial cell density, and cell loss continues at an accelerated rate after keratoplasty. [3] [4] [5] The exact pathophysiological mechanism for rapid endothelial cell loss after keratoplasty is not completely understood; however, mechanical surgical trauma, inflammation, and subclinical immunologic rejection leading to endothelial cell apoptosis are the most probable explanations. [6] [7] [8] [9] Various strategies have been developed to decrease the dramatic postsurgical endothelial cell loss in EK. Most of the strategies focus on reducing mechanical surgical trauma by improving the surgical techniques. 10 Alternative strategies include transfer of cultivated endothelial cells, 11 reduction in oxidative stress-induced apoptosis by genetic 12, 13 or pharmacological intervention, 14 promoting endothelial cell replication, 15 and better eye banking techniques. 16, 17 Hypoxia preconditioning, by exposure to a sublethal dose of hypoxia, can protect many cell types and organs from subsequent lethal trauma, 18, 19 and it has been shown to protect cultured human corneal endothelial cells from lethal doses of oxidative stress. 20 In addition to depressing the mitochondrial function, hypoxia upregulates cell survival genes controlled by the nuclear transcription factor, hypoxia-inducible factor-1a (HIF1a), increasing resistance to apoptotic cell damage. 21 In the presence of oxygen, HIF1a is continually hydroxylated in cytoplasm by prolylhydroxylases. Hydroxylated HIF1a is recognized by the von Hippel-Lindau factor, which directs HIF1a to the proteasome for degradation. When oxygen is limiting, HIF1a can migrate to the nucleus, and bind to hypoxia response elements thereby activating hypoxia-inducible genes. Two prominent examples of HIF1a inducible genes are vascular endothelial growth factor (VEGF) and erythropoietin. FG-4592, which is currently in clinical trials for anemia, 22 is a hypoxia-inducible factor, prolyl hydroxylase inhibitor (HIF-PHI), 23 thereby preventing HIF1a degradation leading to induction of hypoxia response elements, which indicates that FG-4592 could be used to induce protective factors without inhibiting the mitochondrial function.
In this study, we examined the potential of hypoxia preconditioning to protect corneal endothelial cells from mechanical stress. We found that hypoxia or FG-4592 can significantly protect corneal endothelial cells in whole rabbit and human corneas that were subjected to sonication-induced mechanical stress and can protect cultured human corneal endothelial cells subjected to oxidative stress. Moreover, FG-4592 protected endothelial cells subjected to perioperative procedures mimicking Descemet stripping automated endothelial keratoplasty (DSAEK). These results indicate that FG-4592 preconditioning has the potential to protect corneal endothelial cells during EK.
MATERIALS AND METHODS

Rabbit Corneal Damage Model
Rabbit eyes were obtained from Pel-Freez Biologicals (Rogers, AR) within 24 hours of death and shipped overnight on ice. After trimming and sterilizing with 1% iodine, each cornea was dissected and rinsed at least 6 times with sterile phosphate-buffered saline (PBS) in a tissue culture hood. The cornea was placed in a 12-well plate, immersed in 2 mL Dulbecco modified Eagle medium (DMEM) tissue culture medium with an antibiotic-antimycotic and 200 mM glutamine and maintained at 37°C for 27 hours.
Rabbit corneas were divided into 4 groups ( Table 1) . Group 1 corneas were placed in a 5% CO 2 tissue culture incubator (balance room air) for 27 hours without sonication treatment. Group 2 corneas were placed in a hypoxia chamber (Coy Laboratory Products, Inc, Grass Lake, MI), 5% CO 2 , 0.5% O 2 , balance N 2 , for 2 hours 20 and then moved to the group 1 incubator for another 25 hours. Group 3 corneas were placed in the 5% CO 2 incubator for 3 hours and then taken out to damage the endothelial surface by sonication. The cornea, supported in the 12-well plate filled with the culture medium was placed under the Sonic Dismembrator Model 100 (Fisher Scientific, Pittsburgh, PA), with the endothelial surface facing up, using a stainless steel tip (diameter 3 mm). The tip was lowered to just touch the fluid surface in the center of the cornea. A sonication pulse at power setting 1 was released for 2 seconds. The cornea was again placed in the incubator for 24 hours. Group 4 corneas were first placed in the hypoxia chamber for 2 hours and then moved to the 5% CO 2 incubator for 1 hour; in turn, their endothelial surfaces were damaged by sonication and again placed in the 5% CO 2 incubator for another 24 hours.
Endothelial damage was measured using a slightly modified procedure following the method of Terry et al. 10 After treatment and culturing, corneas were washed with PBS, and the endothelial surface was stained with 0.2% trypan blue for 2 minutes and washed with PBS 3 times. The corneal image was taken under a dissection microscope (SMZ1500; Nikon USA, Melville, NY). The damaged endothelial surface was measured by quantitative analysis of the image in Adobe Photoshop CS5. Damaged area % = pixels of the trypan blue-stained area/pixels of the entire corneal area.
Human Corneal Endothelial Cell Model
To provide guidance for the dosage of FG-4592 (Sigma, St. Louis, MO), a human corneal endothelial cell line 24 (HCEC) was used. Sonication was not considered appropriate for cells attached to a tissue culture plate, so tertbutyl hydroperoxide (tBHP) was applied to damage cells. The HCEC were seeded in 12-well plates at 2 · 10 5 cells/well in 1 mL Opti-MEM with 10% fetal calf serum (FBS). At approximately 60% confluence, the cells were changed to Opti-MEM with 0.5% FBS for 6 hours. The medium was then changed to include FG-4592 at 0, 1, 5, 10, 50, and 100 mM diluted in DMEM from a 50 mM stock dissolved in dimethyl sulfoxide. After maintaining for 2 hours, tBHP was added to the cells at the concentration of 1 mM for another 2 hours. 
Staining and Counting Damaged Cells
The cells were dissociated with trypsin and collected by centrifugation. The cell pellet was suspended in 300 mL PBS. Then, 100 mL of the cell suspension was taken and mixed with 100 mL of 0.2% trypan blue. After staining for 2 minutes, cells were counted with a Cellometer Auto T4 (Nexcelom Bioscience LLC, Lawrence, MA) to determine the percent of trypan blue-positive cells.
Human Corneal Damage Model
Human corneas deemed unsuitable for transplantation were obtained from the VisionFirst eye bank, Indianapolis, IN. Unlike the rabbit corneas, the human corneas arrived with variable amounts of endothelial damage. To determine this baseline damage, corneas were washed with PBS once, stained with 0.2% trypan blue for 2 minutes, washed with PBS 3 times, and an image was recorded. Corneas were placed in a 6-well plate and immersed in 6 mL of DMEM with an antibiotic-antimycotic and 200 mM glutamine.
All human corneas were divided into 3 groups (Table  1 ) and maintained at 37°C for a total of 27 hours. Corneas in group 1 were placed in a 5% CO 2 tissue culture incubator (balance room air) for 3 hours. Then, the endothelial surface was damaged by applying sonication, and culturing was continued for 24 hours. Corneas in group 2 were first put in a hypoxia chamber (5% CO 2 , 0.5% O 2 balance N 2 ) for 2 hours, then moved to the normoxic incubator for 1 hour. The endothelial surface was damaged by applying sonication, as described above, and culturing was continued for 24 hours. Corneas in group 3 were placed in the tissue culture incubator with 5% CO 2 (normoxia condition), but the medium contained 50 mM FG-4592 for the first 2 hours and was then changed to the regular medium for 1 hour. After the endothelial surface was damaged by applying sonication, the cornea was maintained for another 24 hours. Net damage of the human corneas was evaluated using the following formula: net damage = % area of final trypan blue staining 2 % area of initial staining, using the same procedure as for rabbit corneas.
Perioperative EK Model
Ten pairs of human donor corneas (n = 20) were included in this phase of the study. Tissue having severe endothelial stress lines, significant Descemet folds, guttae, or endothelial cell density ,2000 cells/mm 2 by specular microscopy was excluded. Each pair of excised corneoscleral rims was initially stored in Optisol-GS (Bausch & Lomb, Rochester, NY) and then randomized to 1 of 2 different groups (Table 1 ). Tissue in group 1 (FG-positive group) was placed in 20 mL DMEM (HEPES buffered, 0 bicarbonate, Ref. #12320-032; Gibco Laboratories, Gaithersburg, MD) with 50 mM FG-4592. Tissue in group 2 (FG-negative group) was placed in plain DMEM without FG-4592. Both groups were incubated for 2 hours at 37°C in an incubator (Incucell Model LSIS B2V/IC 55, BMT Medical Technology, Czech Republic) in air. After 2 hours, tissues in both groups were transferred to plain DMEM and incubated for another 1 hour.
The corneoscleral rim was placed endothelial side up and stained with 0.06% trypan blue dye (concentration used by eye banks for EK preparation, C-Blue; Stephens Instruments, Lexington, KY) for 1 minute. The dye was washed with 0.9% balanced salt solution, and a baseline preoperative image was taken. Tissue was mounted on an automated microkeratome (Moria, Antony, France), and baseline ultrasonic pachymetry (Corneo-gage; Sonogage, Inc, Cleveland, OH) was measured. The epithelium was scraped off with a wet Merocel sponge, and lamellar dissection was performed using a 350-mm head. The central ultrasonic pachymetry reading of the posterior donor tissue was noted. Tissue was then placed on a Teflon block with the endothelial side up and punched with an 8-mm corneal trephine.
To mimic use with DSAEK, the donor button was placed in a graft insertion device (Busin donor glide, width 3.2 mm · length 2 mm, Cat #19098; Moria SA) and pulled through using microforceps to place it back in the Teflon block with the endothelial side up. The endothelium was stained again with trypan blue dye (0.06%) for 1 minute, washed with balanced salt solution to remove extra stain, and a final postoperative image was taken. Imaging was done using an operating microscope (Model M220; Leica, Wetzlar, Germany) and HD camera (Microcast HD pro-lite; Optronics, Goshen, IN). Tissue preparation, lamellar dissection, and image analysis were performed by 2 masked corneal surgeons.
Endothelial cell loss was calculated using Fiji segmentation software as previously described. 25, 26 The endothelial cell loss difference was calculated by subtracting endothelial cell loss of the baseline preoperative image from that of the final postoperative image.
Statistical Analysis
All statistical tests were 2-tailed, and P , 0.05 was considered significant. Cell loss differences between groups were assessed with the Student t test for experiments with nonpaired corneas; the paired t test was used for experiments with paired donor corneas. Statistical analysis was done using Microsoft Excel 2010.
RESULTS
To determine whether hypoxia preconditioning had any potential for protecting endothelial cells from mechanical damage, we first used rabbit corneas that were exposed to 0.5% oxygen for 2 hours. Figure 1 shows that after collection of rabbit eyes, shipment overnight, dissection of corneas, and 27 hours of organ culture, 6% to 7% of the endothelial area was trypan blue positive, which was not significantly different between normoxia and 2 hours of hypoxia exposure, which indicates that the hypoxia exposure itself was not damaging. For corneas subjected to mechanical stress through sonication, damage was 52% 6 20% (SD) for normoxia and 37% 6 21% (SD) for hypoxiapretreated corneas. The difference was modest but significant, P = 0.024. This result shows that hypoxia preconditioning has the potential to protect the endothelium from mechanical stress.
Because hypoxia chambers are unwieldy, we examined whether a pseudohypoxic state by simple treatment with the prolyl hydroxylase inhibitor FG-4592 could also provide protection. To determine the optimal dose of FG-4592 to use, we evaluated whether FG-4592 could protect cultured human corneal endothelial cells from oxidative stress provided by 2 hours of 1 mM tBHP. Figure 2 shows representative phase contrast images of HCEC showing increased light-scattering after exposure to tBHP that is lessened by preconditioning with FG-4592. Analysis after collection of cells and trypan blue staining showed that 50 mM FG-4592 significantly reduced cell damage from 43% to 29%, P , 0.001 (Figure 2 , Right panel). These results indicate that FG-4592 also has the potential to protect endothelial cells.
The sonication model was then repeated with human corneas, and both hypoxia and FG-4592 were tested. Because the human corneas were delivered in variable conditions, the initial staining was subtracted from the final staining to determine the % damage caused by each test condition. Figure 3 shows that again approximately 50% of the area was damaged by sonication, which was reduced to about 40% with either hypoxia or FG-4592 pretreatment. This 10 percent difference was significant to just below a P value of 0.05, n = 12 per condition.
Finally, we asked whether human donor buttons prepared for EK and subjected to pulling through a Busin glide were also protected by FG-4592. Table 2 describes the data from the 10 donor pairs. Mean final endothelial cell loss was 21.1% 6 5.6% in the FG-negative group versus 15.8% 6 4.2% in the FG-positive group (P = 0.00002). The mean endothelial cell loss difference (final endothelial cell loss 2 baseline endothelial cell loss) was 19.7% 6 4.7% in the FGnegative group versus 15.1% 6 3.9% in the FG-positive group (Fig. 4 , P = 0.000005).
DISCUSSION
The results of this in vitro pilot study suggest that hypoxia preconditioning, either by direct hypoxic incubation or 1  66  282  2488  2725  639  624  2  46  184  3472  3448  654  611  3  70  72  2053  2066  562  655  4  50  48  2370  2415  479  485  5  50  114  2890  3096  608  600  6  54  100  2288  2342  559  630  7  41  183  2439  2494  489  496  8  71  54  2801  2967  908  797  9  62  132  3040  3236  917  869  10  66  55  2703  2833  586 pseudohypoxia through FG-4592 incubation can reduce corneal endothelial cell loss during mechanical stress. Hypoxiapreconditioned human and rabbit corneas showed 19% and 29% less cell loss, respectively, relative to controls (Table 3) , which were both significant at P , 0.05. FG-4592 reduced endothelial cell loss associated with preparation and insertion of DSAEK grafts by 23% relative to the control (Table 3) . This supports the hypothesis that exposure to FG-4592 increases corneal endothelial cell resistance to apoptosis and may also provide protection during surgical trauma as well. FG-4592 is an orally available drug currently under clinical trials for treating anemia in patients with chronic kidney disease, 22, 23 targeted to increase erythropoietin availability. FG-4592 inhibits the enzyme prolyl hydroxylase, which leads to stabilization and an increased activity of HIF-1a, which enters the nucleus and increases the expression of antiapoptotic genes responsible for enhanced survival, growth, and metabolism of the cells. 23, 27 FG-4592 acts as a hypoxia mimetic agent leading to a cellular environment similar to hypoxia, although the oxidative function of the mitochondria remains intact.
The effect of hypoxia preconditioning and its protective role in the central nervous system and ischemic stroke has been extensively studied. [28] [29] [30] Recent studies have also demonstrated the protective role of hypoxia in ocular tissues such as the retina and corneal endothelial cells to different forms of injury. 31, 32 Cheng et al 20 studied the effect of hypoxia preconditioning on corneal endothelial cells. They used 2 different reactive oxygen species-generating cytotoxins, tBHP and paraquat, to induce oxidative damage to the corneal endothelium. Hypoxia preconditioning was achieved by keeping the corneas in a hypoxia glove box. They assessed cell death by flow cytometric analysis using annexin V and propidium iodide double staining. They concluded that 2 hours of hypoxia preconditioning was sufficient to mobilize HIF1a and protect human corneal endothelial cells from reactive oxygen species-producing cytotoxins. Iron is also a cofactor in hydroxylation of HIF1a. A study by Zhu et al showed that desferrioxamine, an iron chelator and "hypoxia mimetic," had neuroprotective properties in the retina against lethal ischemic injury. 31 Trypan blue dye used in this study stains the area of bare Descemet membrane with a denuded corneal endothelium and devitalized broken cells that remain attached to Descemet membrane. Thus, trypan blue staining is labeling areas where cells were lost and where cells have entered endstage apoptosis. Also, we noted that trypan blue staining was more prominent in areas of mechanical stress lines and corneal folds created, whereas when the DSAEK button was passed through the Busin glide. Albon et al 7 found more apoptotic cell loss in areas of corneal folds. Another study by Gain et al 32 showed the absence of cytoprotective (antiapoptotic) factors such as Bcl-2 and heat shock proteins being characteristically absent in the endothelial cells located in corneal folds. Thus, mechanical stress is a powerful contributor to endothelial cell loss, and strategies such as hypoxia preconditioning may be helpful but cannot totally overcome these physical forces.
The fellow-eye design used in the EK damage model minimized confounding factors for endothelial cell loss between both groups. The baseline endothelial cell density measured by specular microscopy was higher in the FG-positive group (P = 0.004). However, the specular image represents a very small area of the endothelium. The baseline images of the entire corneal endothelial surface did not show a statistically significant difference in baseline endothelial cell loss between both groups (P = 0.08, Table 2 ).
The range of final endothelial cell loss in the keratoplasty model, as calculated by Fiji software, was 10% to 32%. This was comparable to the 14% to 34% range of endothelial cell loss reported by Jardine et al using Fiji software with a Descemet membrane endothelial keratoplasty model. 26 We agree with their assessment that Fiji segmentation software is an accurate, efficient, and reproducible means for quantifying endothelial cell loss and that it could be a very helpful tool for the eye banks to assess the percentage of corneal endothelial cell damage during endothelial graft preparation.
This study has several limitations. This was an ex vivo, experimental pilot study. The long-term side effects of FG-4592 on intraocular tissues are unknown. Utilization of FG-4592 requires incubation in a cell culture media at 37°C to achieve the hypoxia mimetic effect. The study was not able to differentiate between endothelial cell loss caused by direct mechanical trauma and endothelial cell loss resulting from storage conditions. Larger follow-up studies are needed to verify the findings.
In summary, surgically induced trauma from a combination of donor preparation and surgical implantation is an important cause of endothelial cell loss with EK. FG-4592, a prolyl hydroxylase inhibitor that creates pseudohypoxia, has the potential to be one of the strategies used to reduce endothelial cell loss during donor preparation and implantation of EK grafts and thus improve the number of viable corneal endothelial cells transferred to the graft recipient.
